Found: 9
Select item for more details and to access through your institution.
Aberrantly low STAT3 and STAT5 responses are associated with poor outcome and an inflammatory gene expression signature in pediatric acute myeloid leukemia.
- Published in:
- Clinical & Translational Oncology, 2021, v. 23, n. 10, p. 2141, doi. 10.1007/s12094-021-02621-w
- By:
- Publication type:
- Article
Histopathology (International Neuroblastoma Pathology Classification) and MYCN status in patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.
- Published in:
- 2001
- By:
- Publication type:
- journal article
International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Prevalence and clinical implications of NRAS mutations in childhood AML: a report from the Children's Oncology Group.
- Published in:
- 2011
- By:
- Publication type:
- Letter
Molecular alterations of the IDH1 gene in AML: a Children's Oncology Group and Southwest Oncology Group study.
- Published in:
- 2010
- By:
- Publication type:
- journal article
DNA repair polymorphisms and outcome of chemotherapy for acute myelogenous leukemia: a report from the Children's Oncology Group.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Postremission therapy for children with acute myeloid leukemia: the children's cancer group experience in the transplant era.
- Published in:
- Leukemia (08876924), 2005, v. 19, n. 6, p. 965, doi. 10.1038/sj.leu.2403763
- By:
- Publication type:
- Article
PTPN11 mutations in pediatric patients with acute myeloid leukemia: results from the Children's Cancer Group.
- Published in:
- Leukemia (08876924), 2004, v. 18, n. 11, p. 1831, doi. 10.1038/sj.leu.2403492
- By:
- Publication type:
- Article
Merging of the National Cancer Institute-funded cooperative oncology group data with an administrative data source to develop a more effective platform for clinical trial analysis and comparative effectiveness research: a report from the Children's Oncology Group
- Published in:
- Pharmacoepidemiology & Drug Safety, 2012, v. 21, p. 37, doi. 10.1002/pds.3241
- By:
- Publication type:
- Article